Literature DB >> 16616316

Cervicofacial vascular anomalies. I. Hemangiomas and other benign vascular tumors.

Denise M Adams1, Anne W Lucky.   

Abstract

Before the early 1980s, the lack of an accepted system of nomenclature for vascular anomalies created confusion and frustration for clinicians and patients alike. Scientific advances over the past two decades have, however, led to international consensus among experts on a system of disease classification that comprises vascular tumors and vascular malformations. The most common vascular tumor is hemangioma, which is frequently seen in the head and neck area. Some hemangiomas are best left untreated, whereas others may cause significant complications and disfigurement, thus requiring intervention. Early recognition and treatment of complications is imperative. This is best accomplished in an interdisciplinary setting, where collaborative treatment strategies are planned on an individual basis. Steroids are the first line of medical treatment. Chemotherapy with vincristine is an effective treatment for complicated lesions, although it requires further evaluation through prospective clinical trials. Because of known neurotoxicity, interferon is used as a last resort, especially in children younger than 1 year of age. Laser therapy and surgical excision are also important therapeutic modalities. This article presents an overview of hemangiomas and other vascular tumors, highlighting cervicofacial lesions and describing critical and underappreciated clinical presentations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616316     DOI: 10.1053/j.sempedsurg.2006.02.010

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  12 in total

1.  Combination of propranolol and sclerotherapy for treatment of infantile parotid hemangiomas.

Authors:  Xiaorong Ma; Mengling Chang; Tianxiang Ouyang; Daili Xu; Miao Xu; Jingwen Ke; Jun Lin; Jun Liu; Jie Yu; Huiping Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Successful use of topical "Ankaferd Blood Stopper" for repetitive bleedings in an infant with infantile hemangioma.

Authors:  Ali Annagür; Hüseyin Altunhan; Murat Konak; Rahmi Ors
Journal:  Int J Clin Exp Med       Date:  2012-08-22

3.  Analysis of the therapeutic evolution in the management of airway infantile hemangioma.

Authors:  Grecia V Vivas-Colmenares; Israel Fernandez-Pineda; Juan Carlos Lopez-Gutierrez; Miguel Angel Fernandez-Hurtado; Maria Antonia Garcia-Casillas; Jose Antonio Matute de Cardenas
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 4.  The role of radiology in head and neck tumours in children.

Authors:  Claire Lloyd; Kieran McHugh
Journal:  Cancer Imaging       Date:  2010-03-03       Impact factor: 3.909

5.  Biomechanical properties of infantile hemangiomas: clinical stage and effect of age.

Authors:  M O Visscher; S A Burkes; D M Adams; A Gupta; R R Wickett
Journal:  Skin Res Technol       Date:  2016-06-05       Impact factor: 2.365

Review 6.  Complex vascular anomalies.

Authors:  Richard G Azizkhan
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

7.  A case series of intraosseous hemangioma of the jaws: Various presentations of a rare entity.

Authors:  Srinivasa R Chandra; Eleanor Chen; Timothee Cousin; Dolphine Oda
Journal:  J Clin Exp Dent       Date:  2017-11-01

Review 8.  Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy.

Authors:  Andreas Fette
Journal:  ScientificWorldJournal       Date:  2013-05-20

9.  Glossectomy in the severe maxillofacial vascular malformation with jaw deformity: a rare case report.

Authors:  Min-Hyeog Park; Chul-Man Kim; Dong-Young Chung; Jun-Young Paeng
Journal:  Maxillofac Plast Reconstr Surg       Date:  2015-11-14

Review 10.  A primary cavernous hemangioma of the thyroid gland: A case report and literature review.

Authors:  Jie Miao; Shubo Chen; Yongcai Li; Lin Fu; Hui Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.